Abstract
Introduction
To date, three types of molecules have been developed for the treatment of
human diseases. These major classes of molecules are 1) small molecules, 2)
antibodies, and 3) peptides. Currently, the majority of the therapeutic
molecules developed and marketed are small molecules. However, with the recent
development in several technologies in the areas of peptide synthesis,
screening, stability, and modifications, peptides are now recognized as lead
molecules for therapeutics.
This report contains a comprehensive analysis of peptide-based technologies,
peptides for therapeutics, and their delivery mechanisms. In addition, it
provides a thorough analysis of companies that have developed new peptides and
related technologies.
Report Overview
This report analyzes the current peptide market. In addition, it features an
analysis of therapeutic peptide products in multiple disease indications, as
well as an up to date overview of key patent issues in this space. Numerous
peptide therapeutic companies are profiled and details of their
specialization, capabilities, and services are provided. The Report offers
multiple experts' opinion on current application and issues related to
peptides. Results from an analysis of a proprietary survey conducted on
current issues in peptides are a key component of this report as well.
Learn about critical issues in this space such as:
- Advances made in peptides discovery
- Therapeutic potential of peptides in multiple diseases
- New peptides introduced to market
- Issues in peptides delivery
- Key players in peptide manufacturing, formulations and research
- Past and future growth in multiple peptide segments
- Challenges and obstacles in developing peptides
Questions Answered
- What are the current markets and future prospects for peptides?
- What are the major and minor steps required for the success of peptides in
multiple disease conditions?
- Who are the current companies in peptide formulation, manufacturing and
therapy?
- What is the current status of key peptide products?
- What peptides related issues are making the news?
| 
View Cart
